The study of human papillomavirus replication has been hampered by the lack of an in vitro system which reliably supports virus replication. Recent results from the bovine papillomavirus (BPV) 
replication. In addition, we have detected an El-associated ATPase and GTPase activity, which is likely part of an energy-generating system for the helicase activity which is predicted for this protein. The human papillomavirus type 11 El and E2 proteins possess the same replication-associated activities exhibited by the corresponding BPV proteins, suggesting that the replication activities of these viruses are tightly conserved.
Human papillomaviruses (HPVs) are a family of small DNA viruses which induce benign hyperproliferative lesions of the cutaneous and mucosal epithelia. Of the 70 different virus types which have been identified, more than 20 are associated with anogenital lesions (11) . Two groups of genital-associated viruses are recognized: those including HPV types 6 and 11 (HPV-6 and HPV-11) which induce primarily benign lesions, including condyloma acuminata, and those such as HPV-16 and HPV-18, which are associated with intraepithelial neoplasia and are considered to be at high risk for progression to cervical cancer (45) . Greater than 85% of cervical carcinomas examined are associated with infection by the high-risk HPVs (35) .
The PV life cycle is exquisitely attuned to the progressive vertical differentiation which accompanies maturation of the keratinocytes in the epidermis. The actively dividing basal cells maintain the virus as a low-copy-number nuclear plasmid. Vegetative viral replication occurs only in the suprabasal daughter cells, which are nondividing and committed to terminal differentiation. Replication of HPV DNA in cell culture has met with only limited success. Cell lines derived from genital lesions containing HPV-31 (2) and HPV-16 (37) have been shown to maintain the extrachromosomal viral replicon with continued passage in culture, and recently, transfection of HPV plasmid DNAs has been shown to permit transient replication of PV DNA if cotransfected with expression plasmids for the El and E2 proteins (7) . It is presumably our inability to sufficiently mimic all facets of keratinocyte differentiation in vitro which has precluded the establishment of a productive system for PV infections in cell culture and has limited the genetic analysis of the HPV replication functions.
Bovine PV (BPV) has a genomic organization similar to that of the HPVs (Fig. 1A ) (1) , and because it can stably * Corresponding author.
replicate as an extrachromosomal element in some established mouse cell lines, BPV has been the model of choice for the study of PV replication functions (12) . Both genetic and biochemical evidence have shown that BPV replication is dependent on the virus-encoded El and E2 proteins. A variety of deletion, insertion, and frameshift mutations in both the El and E2 open reading frames (ORFs) leads to integration of the viral DNA into the host cell chromosome (12, 20) . In transient-replication assays, as well as in a cell-free in vitro replication system, El and E2 are the only viral proteins required for replication of an origin-containing plasmid (40, 43) .
The El protein is a nuclear, ATP-binding phosphoprotein which binds to the viral origin of replication (3, 36, (39) (40) (41) 43) . On the basis of amino acid sequence homologies with the simian virus 40 (SV40) large T-antigen (T-Ag), it has been suggested that El possesses ATPase and helicase activities (8, 36, 39) . Mutation of a conserved proline (Fig. 1B, *) in the ATP-binding domain of T-Ag makes SV40 temperature sensitive for viral DNA replication (9) . This proline residue is well conserved among the PVs, including HPV-ll (Pro-479). Mutation of this residue in BPV El inhibits viral DNA replication (39) . HPV-11 El also contains a basic tract of amino acids (119 to 127) similar to that of BPV El and T-Ag (Fig. 1B) which may function as a nuclear localization signal (8, 36, 39) .
The E2 protein is a sequence-specific DNA-binding transcriptional modulator encoding both activating and repressing functions (for a review, see reference 20) . Computer analysis predicts extensive similarities in secondary structure among the sequenced PV E2 proteins (34) . Furthermore, the E2 transactivation activities are conserved as the PV proteins are interchangeable in their ability to activate an enhancer containing the canonical DNA-binding site for the E2 protein, ACCN6GGT (18, 19, 32 (3, 27) . Furthermore, this complex is localized to the viral origin of replication (on), which contains the sequences that regulate the initiation of replication (40, 43) . In addition, the complex binds to a region -200 bp upstream of the oni that is associated with the onset of bidirectional replication (27, 42) . The on maps to a 60-nucleotide DNA fragment centered on the unique HpaI site of BPV (7911 to 22) and contains binding sites for both the El and E2 proteins as well as an A+T-rich sequence similar to that found in the origins of other papovaviruses (40, 43) . Nucleotide sequence comparison of the HPVs indicates that these viruses contain a similarly organized region spanning nucleotide 1 (7, 40) .
In order that we might study HPV DNA replication in more detail and to circumvent the lack of an in vitro tissue culture system, we have undertaken a biochemical study similar to those recently initiated for BPV. The considerable sequence similarities between the HPV and BPV El and E2 proteins suggest that the replication and transcriptional modulatory functions may be tightly conserved. In this paper we describe the construction of baculovirus-based plasmids to overexpress the El and E2 polypeptides of HPV-11. We have conducted a preliminary analysis of the biochemical activities of the partially purified proteins and demonstrate that both proteins exhibit the replication-associated activities possessed by the counterpart BPV proteins. It is anticipated that these purified proteins can be used to study viral replication in a cell-free system.
MATERLALS AND METHODS
Construction of baculovirus El and E2 expression plasmids. The sequences encoding the HPV-11 El and E2 proteins were isolated by polymerase chain reaction (PCR) amplification from the HPV-11 clone pW79 (15 Immunoprecipitations. Immunoprecipitations were performed as described previously (33) . Peptide antisera were used at a dilution of 1:50. Immune complexes were washed four times with lysis buffer containing 300 mM NaCl, suspended in sample buffer, and analyzed by polyacrylamide gel electrophoresis. and the ATP-binding domain is included for the HPV-ll and BPV-1 El proteins and the SV40 T-Ag. Amino acid differences between the E2 protein used in this study and the prototype HPV-ll are indicated above the E2 ORF. Also above each ORF are indicated the peptides which were synthesized to raise the E2 (Ab4089) and El (Ab4O88) antisera used in this study. (C) Flow chart of the construction of baculovirus transfer DNAs used for recombination into AcMNPV. PV fragments were generated by PCR. El was generated as two pieces which were recombined at the unique internal SphI site. These fragments were cloned into baculovirus transfer vector pVL1393. 1A) were cloned into the baculovirus vector pVL1393 by PCR amplification from a clone of HPV-11. The viral DNA for this clone was isolated from the lesion of an adolescent patient with anogenital warts which contained exclusively episomal copies of HPV-11 (15) . The plasmid pW107 contains PV sequence from nucleotides 829 to 2781; pW104 spans nucleotides 2723 to 3826 (Fig. 1C) . Both are expected to initiate translation at the authentic PV ATGs for El and E2. Recombinant baculoviruses were established, and viral stocks (vEl and vE2) were purified by standard techniques (31, 38) .
The integrity of the PCR-amplified DNAs was confirmed by DNA sequencing of the entire coding regions. Eleven nucleotide differences compared with prototype HPV-11 (10) were identified in this new isolate and are listed in Table 1 along with the predicted change in the amino acid sequence. (Fig. 2) . The predicted molecular sizes for HPV-ll E2 and El are 41.7 and 73.5 kDa, respectively. The decreased mobility of El may be indicative of posttranslational modifications to the protein and/or a specific primary sequence which results in aberrant migration.
The identity of these proteins was confirmed by Western blot analysis using antisera generated against El (Ab4088) or E2 (Ab4089) peptides (Fig. 1B) . otEl readily detects an El protein of 80 kDa in nuclear extracts from cells infected with the vEl recombinant baculovirus (Fig. 3B) which is not present in cells infected with either vE2 or wt baculovirus.
Likewise, aLE2 detects a 42.5-kDa protein only in cells infected with the vE2 baculovirus. Coinfections with the vEl and vE2 viruses (Fig. 3) lead to expression of both proteins. Approximately 30% of the total El and E2 protein is soluble, most of which is present in the nucleus and can be recovered in a 300 mM NaCl nuclear wash.
One of the potential advantages of the baculovirus system relative to Escherichia coli is that large quantities of posttranslationally modified protein can be isolated. The BPV El and E2 proteins are both phosphorylated (24, 36, 39) , and phosphorylation may be an important regulator of the activities of both of these proteins (22, 25) . To (Fig. 4) . Proteins of the expected molecular sizes for El and E2 were immunoprecipitated in the presence of the appropriate Ab and detected by autoradiography, demonstrating that HPV-11 El and E2 proteins are phosphorylated. The relatively low level of phosphorylation of HPV-11 E2 is consistent with that observed for BPV E2, which is modified primarily at only two Ser residues (Ser-298 and Ser-301 [24] (18) or predicted to possess on the basis of their homology to the BPV proteins (8, 27, (39) (40) (41) 43) .
(i) The El and E2 proteins form a molecular complex. The ability of the BPV El and E2 proteins to physically associate is thought to be a prerequisite for their participation in viral replication (27, 43) . The strength of the homology between BPV and the HPVs suggests that El-E2 complexation will also be important for replication of the human viruses. As is shown in Fig. 5, either in the cell are in complex. When El and E2 are cotranslated in vitro, complexation occurs in the absence of nucleic acids, suggesting that the association is a genuine protein-protein interaction (5) .
(ii) The El and E2 proteins are localized to the viral ori. Sequence-specific DNA binding by the BPV El and E2 proteins is an important part of the functions of both proteins in the virus life cycle. Binding to the sequence ACCN6GGT is required by the E2 protein for its functions as both a replication protein (6) and a transcriptional regulator (17, 19, 21, 26, 28) . BPV El exhibits site-specific DNA binding to the viral ori (43) . In addition, the El protein can be localized to DNA by virtue of its complexation with E2 (27) . To determine whether the HPV proteins encode any or all of these properties, we performed an immuno-DNA binding assay.
Extracts from cells infected with vE2, vEl, both vE2 and vEl, or wt baculovirus were immunoprecipitated with either oEl or oxE2, and the protein-beads were allowed to bind to a mixture of end-labelled restriction fragments from a clone of HPV-ll. After unbound DNA was washed away, bound fragments were resolved on a nondenaturing polyacrylamide gel. An E2-containing extract immunoprecipitated with an E2 Ab binds to two DNA fragments, both of which contain at least one ACCGN4CGGT motif (Fig. 6 , fragments G and H), which is believed to represent the high-affinity E2 binding sequence (21) . No specific fragments are immunoprecipitated when the E2 extract is mixed with the El Ab. Interestingly, two fragments contain E2 binding sites of the sequence ACCN6GGT (Fig. 6, fragments A and F) . Neither of these fragments is bound by an E2 extract, suggesting that we are able to detect only high-affinity DNA binding by this assay or that the HPV-11 E2 protein has a more stringent requirement for its binding site than the BPV E2 protein.
When an El extract is used, no specific retention of any DNA fragments is observed, regardless of whether the El or E2 Ab is used. In addition, we have tested a second, epitopically distinct, El antipeptide antiserum as well as El prepared from E. coli and have been unable to detect high-affinity DNA binding by El in either case (data not shown). When the El Ab is used to immunoprecipitate from a coinfected extract, however, El is observed to be associ- ated with the DNA fragment which contains the viral oni (fragment H) as well as fragment G, which contains a high-affinity E2 binding site. Since under these conditions we do not see evidence of high-affinity DNA binding with El alone, the association of El with these fragments is probably by virtue of its complexation with the E2 protein, with E2 providing the binding specificity. It is not known whether El makes any contact with the DNA when complexed with E2. If E2 is solely responsible for the DNA binding observed in this assay, it is somewhat surprising that an equivalent amount of fragment is retained by the coinfected extract when the El Ab is used. In the coinfected extracts only about 10% of the total E2 is complexed with El and immunoprecipitated by the El Ab (Fig. 5 ), yet the signal is equivalent to that of a coinfected extract in which an E2 Ab immunoprecipitates both the complexed and free E2 (Fig. 6) . A potential explanation for this observation is that only a fraction of E2 is capable of binding to DNA and most of this fraction will complex with the El protein. Alternatively, El and E2 together may have enhanced DNA binding capabilities similar to that already described for BPV (43) .
(iii) The El protein exhibits ATPase and GTPase activity.
The El protein from BPV expressed in either COS or 3T6 cells binds ATP (36, 39) , and recent data indicate that the protein also possesses ATPase activity (23 El and SV40 T-Ag (Fig. 1B) (14) .
not bind DNA in a site-specific manner in the absence of E2 also a substrate for the or binds with a substantially lower affinity. to hydrolyze non-ATP In addition to the 80-and 73-kDa El proteins, several oroperty of this protein smaller forms of the El protein are immunoprecipitated with ing ATP still retain 18% an amino-terminal El Ab (Fig. 5) , which suggests that these When we tested the forms represent COOH-terminal truncations of El. Since an -tivity using the beads E2 Ab also immunoprecipitates these smaller forms of El ecific activity was even from coinfected extracts, it suggests that the C terminus is ity. In this instance, the dispensable for complexation with E2. This is in contrast to lty was almost 11 times a study which mapped the sequences required for complexg extract (Fig. 7) .
ation of the BPV El and E2 proteins to the COOH terminus (6, 40) . Expression of the replication proteins, not the interaction of the viral proteins with the cellular machinery, seems to be the limiting factor for virus replication in the different cell types. Therefore, the information gathered from the study of viral DNA replication using HPV-11 should be applicable to most of the other mucosal and cutaneous PV systems as well.
